发明名称 |
MULTICOMPONENT CRYSTALS COMPRISING DASATINIB AND SELECTED CO-CRYSTAL FORMERS |
摘要 |
Provided are a multicomponent crystalline system (co-crystal), use thereof, as well as a process for obtaining the same. The said multicomponent crystalline system (co-crystal) comprises Dasatinib and a second compound selected from methyM-hydrobenzoate, nicotinamide, ethyl gallate, methyl gallate, propyl gallate, ethyl maltol, vanillin, menthol, or (1R,2S,5R)-(−)-menthol.; |
申请公布号 |
US2015133463(A1) |
申请公布日期 |
2015.05.14 |
申请号 |
US201314406339 |
申请日期 |
2013.06.13 |
申请人 |
BASF SE |
发明人 |
Chiodo Tiziana;Hafner Andreas;Hintermann Tobias;Salvador Beate;Szelagiewicz Martin;Blatter Fritz;Siebenhaar Bernd;Vossen Marcus |
分类号 |
C07D417/12;C07D213/82;A61K31/506;C07C47/58;C07C35/12;C07C65/03;C07D309/40 |
主分类号 |
C07D417/12 |
代理机构 |
|
代理人 |
|
主权项 |
1. A multicomponent crystalline system comprising:
a compound of formula 1and
a second compound selected from the group consisting of methyl-4-hydroxybenzoate, nicotinamide, ethyl gallate, methyl gallate, propyl gallate, ethyl maltol, vanillin, menthol, and (1R,2S,5R)-(−)-menthol. |
地址 |
Ludwigshafen DE |